We use cookies to improve site performance and enhance your user experience. If you'd like to disable cookies on this device, please see our cookie management page.
If you close this message or continue to use this site, you consent to our use of cookies on this devise in accordance with our cookie policy, unless you disable them.

Close

Find a share

Search for UK shares

Search

Market movers

United Kingdom
movers are constituents of the FTSE 350.
% GainersCompany
content
IC ViewLastChange
Hikma Pharmaceuticals PLC
HIK:LSE
1,733
GBX
+108.00
+6.65%
RPC Group PLC
RPC:LSE
559.00
GBX
+33.50
+6.37%
Centamin PLC
CEY:LSE
61.15
GBX
+3.10
+5.34%
African Barrick Gold PLC
ABG:LSE
218.80
GBX
+10.90
+5.24%
Associated British Foods PLC
ABF:LSE
2,679
GBX
+116.00
+4.53%
BTG PLC
BTG:LSE
700.00
GBX
+25.00
+3.71%
Bank of Georgia Holdings PLC
BGEO:LSE
2,458
GBX
+83.00
+3.49%
Lonmin PLC
LMI:LSE
185.80
GBX
+5.50
+3.05%
easyJet plc
EZJ:LSE
1,423
GBX
+42.00
+3.04%
EVRAZ plc
EVR:LSE
130.00
GBX
+3.60
+2.85%
As of Sep 30 2014 16:35 BST.

Companies news

Who bought who
Deal status
Deal value
Date
Aeon Co LtdacquiredDaiei IncAnnounced262.19m24 Sep 2014
1-1 of 1 results

Companies news

Financial Times articles may require a separate login and/or subscription to FT.com

Snoop Dogg joins Reddit funding round
Elisabeth Murdoch to end Shine era
Mercer strips Pimco funds of top rating
Groceries watchdog quizzes Tesco on code
Ebay free to focus on its core

Featured company

Epistem Holdings PLCEHP:LSE

Epistem Holdings Plc (Epistem) is a United Kingdom-based biotechnology company focusing on epithelial stem cells in the areas of oncology, gastrointestinal disease, dermatology and ageing

© Thomson Reuters Click for restrictions.

All markets data located on Investors Chronicle is subject to the Investors Chronicle Terms & Conditions.

All content on Investors Chronicle is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Investors Chronicle and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Conditions.

Advertiser reports

Register today and get...

Register today and get...
Please note terms & conditions apply